apocodeine has been researched along with apomorphine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnati, L; Dafeldecker, WP; Fuxe, K; Guarino, J; Kosersky, DS; Neumeyer, JL; Reinhard, JF | 1 |
| Foreman, MM; Mason, NR; Schaus, JM; Titus, RD; Truex, LL | 1 |
| Arana, GW; Baldessarini, RJ; Kula, NS; Lamont, JS; Law, SJ; Neumeyer, JL | 1 |
| Rosazza, JP; Smith, RV | 1 |
| Bodde, HE; Danhof, M; Gubbens-Stibbe, JM; Kruger, P; van der Geest, R; van Laar, T | 1 |
| Chen, Q; Ishige, K; Sagara, Y; Schubert, D | 1 |
| Coudoré, F; Durif, F; Eschalier, A; Libert, F; Richard, D | 1 |
7 other study(ies) available for apocodeine and apomorphine
| Article | Year |
|---|---|
Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
Topics: Analgesics; Animals; Aporphines; Dopamine; Humans; Male; Mice; Neural Pathways; Rats; Reaction Time; Stereotyped Behavior; Structure-Activity Relationship | 1976 |
Aporphines as antagonists of dopamine D-1 receptors.
Topics: Adenylyl Cyclases; Animals; Aporphines; Benzazepines; Binding Sites; Binding, Competitive; Chemical Phenomena; Chemistry; Enzyme Activation; In Vitro Techniques; Rats; Receptors, Dopamine; Retina; Spiperone; Structure-Activity Relationship | 1990 |
Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Aporphines; Binding, Competitive; Cattle; Caudate Nucleus; Chemical Phenomena; Chemistry; Corpus Striatum; In Vitro Techniques; Radioligand Assay; Rats; Receptors, Dopamine; Spiperone | 1981 |
Microbial models of mammalian metabolism.
Topics: Acronine; Animals; Apomorphine; Biotransformation; Dealkylation; Ellipticines; Ergolines; Guinea Pigs; Humans; Hydroxylation; Imipramine; Mammals; Models, Biological; Papaverine; Pharmaceutical Preparations | 1983 |
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease.
Topics: Acetic Acid; Antiparkinson Agents; Apomorphine; Chromatography, High Pressure Liquid; Circadian Rhythm; Glucuronates; Glucuronic Acid; Glucuronidase; Humans; Hydrolysis; Infusions, Intravenous; Linear Models; Male; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Sulfatases; Sulfates; Time Factors | 1997 |
The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.
Topics: Animals; Antioxidants; Apomorphine; Binding, Competitive; Calcium; Cell Death; Cell Line; Cyclic GMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Epinephrine; Glutamic Acid; Hippocampus; Mice; Neurons; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Rats; Reactive Oxygen Species; Receptors, Dopamine D2; Receptors, Dopamine D4 | 2001 |
Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
Topics: Apomorphine; Catechol O-Methyltransferase Inhibitors; Catechols; Gas Chromatography-Mass Spectrometry; Humans; Nitriles; Parkinson Disease; Reproducibility of Results | 2005 |